The Enterprise Value as of November 2024 (TTM) for Protagenic Therapeutics, Inc. (PTIX) is 1.79M

According to Protagenic Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.79M. This represents a change of -66.35% compared to the average of 5.31M of the last 4 quarters.

Protagenic Therapeutics, Inc. (PTIX) Historical Enterprise Value (quarterly & annually)

How has PTIX Enterprise Value performed in the past?

The mean historical Enterprise Value of Protagenic Therapeutics, Inc. over the last ten years is 5.10M. The current 1.79M Enterprise Value has changed 3.40% with respect to the historical average. Over the past ten years (40 quarters), PTIX's Enterprise Value was at its highest in in the September 2021 quarter at 31.00M. The Enterprise Value was at its lowest in in the March 2016 quarter at -3628836.16.

Protagenic Therapeutics, Inc. (PTIX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Protagenic Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Protagenic Therapeutics, Inc. (PTIX) Average Enterprise Value

How has PTIX Enterprise Value performed in the past?

The current Enterprise Value of Protagenic Therapeutics, Inc. (PTIX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Protagenic Therapeutics, Inc. (PTIX) Enterprise Value vs. Peers

How is PTIX’s Enterprise Value compared to its peers?

Protagenic Therapeutics, Inc.’s Enterprise Value is less than Sino Biopharmaceutical Limited (9.26B), less than ZIVO Bioscience, Inc. (69.51M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Eledon Pharmaceuticals, Inc. (253.07M), less than Rezolute, Inc. (0), less than XOMA Corporation (237.47M), less than Tempest Therapeutics, Inc. (335.94M), less than Aerovate Therapeutics, Inc. (14.50M), less than Adagene Inc. (48.42M), less than Acrivon Therapeutics, Inc. Common Stock (59.89M), less than AN2 Therapeutics, Inc. (200.11M), less than null (5.46M),

Build a custom stock screener for Protagenic Therapeutics, Inc. (PTIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protagenic Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Protagenic Therapeutics, Inc. (PTIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Protagenic Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.